Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1895 2
1896 4
1900 1
1903 1
1910 1
1923 1
1933 1
1934 1
1935 1
1937 1
1939 1
1945 1
1946 3
1947 1
1948 3
1949 2
1951 1
1952 3
1953 5
1954 6
1955 7
1956 8
1958 3
1959 4
1960 10
1961 8
1962 6
1963 6
1964 16
1965 4
1966 19
1967 13
1968 16
1969 25
1970 25
1971 37
1972 20
1973 19
1974 18
1975 19
1976 24
1977 19
1978 27
1979 28
1980 39
1981 43
1982 29
1983 32
1984 37
1985 38
1986 47
1987 37
1988 54
1989 52
1990 56
1991 51
1992 58
1993 55
1994 80
1995 77
1996 68
1997 54
1998 62
1999 68
2000 59
2001 73
2002 59
2003 55
2004 67
2005 80
2006 89
2007 88
2008 94
2009 92
2010 107
2011 120
2012 126
2013 148
2014 132
2015 164
2016 161
2017 170
2018 172
2019 197
2020 201
2021 208
2022 191
2023 214
2024 217
2025 92

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,405 results

Results by year

Filters applied: . Clear all
Page 1
Cryptosporidium.
Chalmers RM, Davies AP, Tyler K. Chalmers RM, et al. Among authors: davies ap. Microbiology (Reading). 2019 May;165(5):500-502. doi: 10.1099/mic.0.000764. Microbiology (Reading). 2019. PMID: 31268415 Free article.
Bispecific antibodies in indolent B-cell lymphomas.
Radhakrishnan VS, Davies AJ. Radhakrishnan VS, et al. Among authors: davies aj. Front Immunol. 2024 Jan 11;14:1295599. doi: 10.3389/fimmu.2023.1295599. eCollection 2023. Front Immunol. 2024. PMID: 38274793 Free PMC article. Review.
Benchmarking Complications Associated with Esophagectomy.
Low DE, Kuppusamy MK, Alderson D, Cecconello I, Chang AC, Darling G, Davies A, D'Journo XB, Gisbertz SS, Griffin SM, Hardwick R, Hoelscher A, Hofstetter W, Jobe B, Kitagawa Y, Law S, Mariette C, Maynard N, Morse CR, Nafteux P, Pera M, Pramesh CS, Puig S, Reynolds JV, Schroeder W, Smithers M, Wijnhoven BPL. Low DE, et al. Among authors: davies a. Ann Surg. 2019 Feb;269(2):291-298. doi: 10.1097/SLA.0000000000002611. Ann Surg. 2019. PMID: 29206677
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.
Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, Kennedy H, Thompson JS, Uddin R, Worrillow L, Chalkley R, van Hoppe M, Ahmed S, Maishman T, Caddy J, Schuh A, Mamot C, Burton C, Tooze R, Davies A, Du MQ, Johnson PWM, Westhead DR. Sha C, et al. Among authors: davies a. J Clin Oncol. 2019 Jan 20;37(3):202-212. doi: 10.1200/JCO.18.01314. Epub 2018 Dec 3. J Clin Oncol. 2019. PMID: 30523719 Free PMC article.
Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury.
Davies AJ, Kim HW, Gonzalez-Cano R, Choi J, Back SK, Roh SE, Johnson E, Gabriac M, Kim MS, Lee J, Lee JE, Kim YS, Bae YC, Kim SJ, Lee KM, Na HS, Riva P, Latremoliere A, Rinaldi S, Ugolini S, Costigan M, Oh SB. Davies AJ, et al. Cell. 2019 Feb 7;176(4):716-728.e18. doi: 10.1016/j.cell.2018.12.022. Epub 2019 Jan 31. Cell. 2019. PMID: 30712871 Free PMC article.
Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR.
Cehajic-Kapetanovic J, Xue K, Martinez-Fernandez de la Camara C, Nanda A, Davies A, Wood LJ, Salvetti AP, Fischer MD, Aylward JW, Barnard AR, Jolly JK, Luo E, Lujan BJ, Ong T, Girach A, Black GCM, Gregori NZ, Davis JL, Rosa PR, Lotery AJ, Lam BL, Stanga PE, MacLaren RE. Cehajic-Kapetanovic J, et al. Among authors: davies a. Nat Med. 2020 Mar;26(3):354-359. doi: 10.1038/s41591-020-0763-1. Epub 2020 Feb 24. Nat Med. 2020. PMID: 32094925 Free PMC article. Clinical Trial.
Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.
Davies AJ, Barrans S, Stanton L, Caddy J, Wilding S, Saunders G, Mamot C, Novak U, McMillan A, Fields P, Collins GP, Stephens R, Cucco F, Sha C, van Hoppe M, Tooze R, Davies JR, Griffiths G, Schuh A, Burton C, Westhead DR, Du MQ, Johnson PWM. Davies AJ, et al. J Clin Oncol. 2023 May 20;41(15):2718-2723. doi: 10.1200/JCO.23.00033. Epub 2023 Mar 27. J Clin Oncol. 2023. PMID: 36972491 Free PMC article. Clinical Trial.
4,405 results